BOPI 03 BR/2023 REPERTOIRE NUMERIQUE 37 pour le décorticage des grains de céréales (maïs et mil-sorgho). Figure 1 Consulter le mémoire ________________________________________ (11) 20867 (51) A61K 31/225 (2018.01); A61K 45/06 (2018.01); A61P 3/06 (2018.01) (21) 1202200329 - PCT/IB2021/051451 (22) 19/02/2021 (30) US n° 62/978,785 du 19/02/2020 (54) Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions. (72) IZBICKA, Elzbieta (US) et STTREEPER, Robert (US) (73) NEW FRONTIER LABS, LLC, 900 NE Loop 410, Suite D-119, SAN ANTONIO, TX 782091403 (US) (74) S.C.P AKKUM, AKKUM & Associates, n° 1777, Rue 6.261, Auditorium Jean Paul II, Quartier Mbankolo, B.P. 4966, YAOUNDE (CM). (57) Pharmaceutical compositions comprising a C1-C4 alkyl ester azelate, such as diethyl azelate (DEA), dimethyl azelate (DMA), di-isopropyl azelate (DiPA), di-isobutyl azelate (DiBuA), and di-2pentyl azelate (D2PA), and methods of, inter alia, improving abnormal 5 lipid levels and treating or preventing dyslipidemias and/or diseases of conditions associated therewith comprising administering to a subject such pharmaceutical compositions, are provided. Fig. 1 Consulter le mémoire
RkJQdWJsaXNoZXIy MTM1NDc3MA==